Clinical evaluation of the effects of esmolol and magnesium sulfate to avoid tachycardia and arterial hypertension during intubation in surgeries
Phase 4
- Conditions
- Intubation and hemodynamicE02.585G09.330.380
- Registration Number
- RBR-9jqdgq
- Lead Sponsor
- niversidade do Sul de Santa Catarina
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Functional class I and II patients, according to the American Society of Anesthesiologists (ASA); submitted to elective surgery; of both sexes; aged between 18 and 65 years; who agree to participate in the study
Exclusion Criteria
Patients with difficult airway; obesity with BMI> 35; in the use of beta-blockers or calcium channel blockers; with heart rate less than 60 bpm; cardiac arrhythmias, renal dysfunction, airway hyperreactivity, hypersensitivity to esmolol or magnesium sulfate; and pregnant women.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method